Paid Clinical Trials in Burlington, VT

As of June 2026, 167 paid clinical trials are recruiting in Burlington, Vermont. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Burlington offers studies at sites including University of Vermont Medical Center for conditions such as Heart Failure, Acute Myeloid Leukemia, Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Trials by specialty in Burlington

Oncology· 49Cardiology· 18Blood cancer· 15Heart disease· 15Lung disease· 9Neurology· 8Brain disorders· 8Pulmonology· 8Women's health· 8Breast oncology· 7Behavioral health· 6Lung oncology· 5

Trials by drug in Burlington

Methotrexate· 5Prednisone· 5Dexamethasone· 4Prednisolone· 3Anastrozole· 2Apixaban· 2Letrozole· 2Cystoscopy· 1Duloxetine· 1
Filter results
Filter results

167 clinical trials

↓ Download CSV

About research studies in Burlington

Burlington has approximately 167 recruiting research studies across a wide range of therapeutic areas. Vermont hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.

Top Research Study Locations in Burlington

Researchers run research studies in Burlington, VT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

SiteSpecializes inActive trials
University of Vermont Medical CenterAcute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer80
University of Vermont and State Agricultural CollegeAcute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm49
University of VermontHeart Failure, AML, AML With Mutated NPM128
The University of Vermont Medical CenterAtrial Fibrillation, Brain Neoplasms, Adult, Malignant, Brain Tumor9
The University of Vermont Medical Center Inc.Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis6
University of Vermont Cancer CenterCancer, Diabetes, Leukemia, Myeloid, Acute3
UVM MCFocal Epilepsy2
Burlington, VT InvestigativeAcute Heart Failure, Heart Failure1
Clinical Research Center, University of Vermont Medical CenterHealthy, Healthy Adult, Healthy Male and Female Subjects1
Clinical Trial SiteGeneralized Myasthenia Gravis1
Department of Orthopaedics & Rehabilitation The Larner College of Medicine at The University of VermontShoulder Arthritis, Shoulder Disease, Shoulder Fractures1
Fletcher Allen Health Care, University of Vermont Medical SchoolGlomerular Filtration Rate1
Golisano Children's Hospital at University of Vermont HealthAcute Kidney Injury, Chronic Kidney Disease(CKD), Epidemiology1
InvestigationalPericarditis, Pericarditis Acute, Recurrent Pericarditis1
LocalRecurrent Pericarditis1
Ohio State University-TelemedicineAdvanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v81
The University of Vermont Children's HospitalFailed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult1
The University of Vermont Larner College of MedicineTraumatic Injury1
The University of Vermont Medical Center, IncCOPD1
UVM Larner College of Medicine MMG/VCTClostridioides Difficile Associated Disease1
UVM Medical Center - 1 South Prospect StreetAutosomal Dominant Polycystic Kidney Disease (ADPKD)1
University of VemontOpioid Use Disorder, Posttraumatic Stress Disorder1
University of Vermont Children's HospitalAVB - Atrioventricular Block, Fetal AVB1
University of Vermont Med CtrHeart Failure1
University of Vermont Medical CentreEssential Tremor1

Active & Upcoming Studies in Burlington (2026)

Recruiting trials in Burlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Cancer & tumors (72 active studies)

Cardiovascular (17 active studies)

Neurology & pain (7 active studies)

Pediatric (4 active studies)

Mental health & behavior (2 active studies)

Vaccines (1 active study)

Diabetes & metabolic (1 active study)

Eye & vision (1 active study)

Common conditions studied in Burlington

  • Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
  • Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
  • Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
  • Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
  • Cancer (3 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
  • Carcinoma, Non-Small-Cell Lung (3 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.

Leading research sponsors in Burlington

  • University of Vermont
  • National Cancer Institute (NCI)
  • University of Vermont Medical Center
  • Children's Oncology Group
  • NRG Oncology

Local regulations and guidelines

Clinical trials in Vermont are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Vermont research additionally follows state public health department oversight and any applicable state privacy statutes.

Compensation & what to expect

How payment typically works
Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
Healthy volunteers
Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Burlington. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
What's included beyond payment
Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
Travel and time
Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
Asking about compensation
Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.

How to find a clinical trial in Burlington

Hipa.ai aggregates every recruiting study in Burlington from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.

Frequently asked questions

How many paid clinical trials are currently recruiting in Burlington?

There are approximately 167 recruiting clinical trials in Burlington, Vermont listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Burlington pay participants?

Most recruiting trials in Burlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Burlington?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Burlington?

The most common conditions under active study in Burlington include Heart Failure (7), Acute Myeloid Leukemia (6), Breast Cancer (4), Anatomic Stage II Breast Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Burlington?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Burlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Burlington?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Burlington?

Recruiting research sites in Burlington include University of Vermont Medical Center, University of Vermont and State Agricultural College, University of Vermont, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Burlington right now?

The largest active categories in Burlington are Cancer & tumors (72), Cardiovascular (17), Neurology & pain (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Vermont

Saint Johnsbury, VT(35)Berlin Corners, VT(25)White River Junction, VT(14)Colchester, VT(10)South Burlington, VT(4)Bennington, VT(3)Woodstock, VT(3)Montpelier, VT(1)Multiple Locations, VT(1)Rutland, VT(1)Williston, VT(1)Winooski, VT(1)

Related healthcare resources in Vermont

Latest Vermont clinical trials research report

Trials by condition in Burlington

Heart Failure· 7Acute Myeloid Leukemia· 6Breast Cancer· 4Glioblastoma· 3